By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Idaho Technology said late on Monday that it is seeking US regulatory approval for five additional pathogens for its FilmArray Respiratory Panel.

The company is seeking 510(k) clearance from the US Food and Drug Administration for Bordetella pertiussis; Chlamydophila pneumoniae; Mycoplasma pneumoniae; Coronavirus 229E; and Coronavirus OC43. According to Idaho Technology, no assays are currently cleared by FDA for the five pathogens.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.